{"id":11916,"date":"2026-06-09T10:58:20","date_gmt":"2026-06-09T01:58:20","guid":{"rendered":"https:\/\/rightfoundation.kr\/en\/?p=11916"},"modified":"2026-06-09T15:55:44","modified_gmt":"2026-06-09T06:55:44","slug":"skbioscience-joins-forces-with-global-institutions-to-advance-rotavirus-vaccine-developmet","status":"publish","type":"post","link":"https:\/\/rightfoundation.kr\/en\/skbioscience-joins-forces-with-global-institutions-to-advance-rotavirus-vaccine-developmet\/","title":{"rendered":"SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"11916\" class=\"elementor elementor-11916\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-22110e80 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"22110e80\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7581e584\" data-id=\"7581e584\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5c9be6c elementor-widget elementor-widget-stad_for_elementor_heading\" data-id=\"5c9be6c\" data-element_type=\"widget\" data-widget_type=\"stad_for_elementor_heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\r\n\t<div class=\"stad-heading stad-heading-single-content stad-padding-0 stad-margin-0\">\t\t<span class=\"stad-heading-single-content-text stad-heading-content-text stad-inline-block\">\r\n\t\t\t\t\t\t\t<span class=\"stad-heading-single-content-text-content\">The RIGHT Foundation has been supporting KRW 1,288,012,992 since 2025 for the \"Inactivated Rotavirus Vaccine Development\" project. Through this project, SK bioscience has entered into a license agreement with the U.S. CDC for an injectable rotavirus vaccine candidate and initiated its development toward future clinical trials and commercialization.<\/span>\r\n\t\t\t\t\t<\/span>\r\n\t<\/div>\t\r\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c3f7b44 elementor-widget elementor-widget-text-editor\" data-id=\"c3f7b44\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.12.1 - 02-04-2023 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p>SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that, after entering into a license agreement with the U.S. Centers for Disease Control and Prevention (CDC), it has initiated process development for an injectable rotavirus vaccine candidate. Following successful process development, the company plans to advance the vaccine through subsequent clinical trials, regulatory approval, and ultimately, commercialization.<\/p><p>Through the license agreement with CDC, SK bioscience has become the first Korean company to receive vaccine technology from the CDC. Previously, the CDC developed the injectable inactivated rotavirus vaccine technology and sponsored a Phase I clinical trial. SK bioscience plans to rapidly implement this technology domestically, establishing a production process that simultaneously enhances vaccine efficacy and reduces costs, while advancing through clinical development and ultimately commercialization.<\/p><p>The project is further supported by the Research Investment for Global Health Technology Foundation (the RIGHT Foundation). SK bioscience signed a research and development funding agreement with the RIGHT Foundation for the rotavirus vaccine process in June 2025.<\/p><p>The RIGHT Foundation is the first non-profit international public-private partnership funding agency in Korea, established through a three-way partnership between the Government of Korea, the Gates Foundation, and Korean life science companies. The foundation provides official development assistance (ODA) that supports essential R&amp;D to reduce the infectious disease burden in low- and middle-income countries.<\/p><p>Rotavirus is a leading infectious disease that causes severe diarrhea and dehydration in children under five worldwide. According to Johns Hopkins University, approximately 24.4% of childhood deaths are due to diarrhea caused by rotavirus infection. With the introduction of rotavirus vaccines, infection rates have declined significantly in high-income countries, resulting in 99% of global rotavirus-related deaths being concentrated in low- and middle-income nations.<\/p><p>The introduction of oral rotavirus vaccines has significantly reduced infection rates in high-income countries, achieving over 85% vaccine effectiveness. However, in low- and middle-income countries, the vaccine effectiveness falls below 50% due to challenging environmental conditions and poor nutritional status. Consequently, these countries are turning their attention to injectable vaccines, which are expected to deliver stronger protective effects than oral formulations.<\/p><p>According to Business Research Insights, the global rotavirus vaccine market is expected to grow from USD 8.12 billion in 2024 to USD 13.9 billion by 2033, representing a CAGR of 6.2% due to increasing demand for rotavirus vaccines.<\/p><p>In addition, UNICEF\u2019s 2024 report shows that UNICEF procured a total of 329 million courses (2\u20133 doses per course) of rotavirus vaccines between 2011 and 2023. Most of these were supplied to Gavi-supported low-income countries. The procurement volume increased from 0.9 million doses in 2011 to 57 million courses for 57 countries in 2023, and demand from Gavi-supported countries is projected to reach approximately 64 million courses by 2028.<\/p><p>Jaeyong Ahn, CEO of SK bioscience, said, \u201cWe are pleased to collaborate with the CDC on the development of a rotavirus vaccine that has the potential to advance global public health. With the support of the RIGHT Foundation, we will continue to develop innovative vaccines to improve child health in low- and middle-income countries and fulfill our responsibility as a company contributing to a healthier future for people around the world.\u201d<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f84e6b8 elementor-widget elementor-widget-text-editor\" data-id=\"f84e6b8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><strong>About SK bioscience<\/strong><\/p><hr \/><p><a href=\"https:\/\/www.skbioscience.com\/en\/main\" target=\"_blank\" rel=\"noopener\">SK bioscience<\/a> is an innovative vaccine and biotech company, committed to vaccine development and manufacturing to enable more equitable access to vaccines around the world. Leveraging strengths on cutting-edge technologies, SK bioscience has been dedicated to promoting human health from prevention to cure across the globe. With the cooperation of domestic and international governments, regulatory agencies, healthcare providers, doctors, and medical experts, all of the SK colleagues are passionately committed to providing high-quality vaccines to those who need them and better public healthcare solutions.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5a0d271 elementor-widget elementor-widget-image\" data-id=\"5a0d271\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.12.1 - 02-04-2023 *\/\n.elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=\".svg\"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block}<\/style>\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/rightfoundation.kr\/en\/wp-content\/uploads\/sites\/2\/2026\/06\/skbio.jpg\" class=\"attachment-large size-large wp-image-11918\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/rightfoundation.kr\/en\/wp-content\/uploads\/sites\/2\/2026\/06\/skbio.jpg 1024w, https:\/\/rightfoundation.kr\/en\/wp-content\/uploads\/sites\/2\/2026\/06\/skbio-768x576.jpg 768w, https:\/\/rightfoundation.kr\/en\/wp-content\/uploads\/sites\/2\/2026\/06\/skbio-667x500.jpg 667w, https:\/\/rightfoundation.kr\/en\/wp-content\/uploads\/sites\/2\/2026\/06\/skbio-650x488.jpg 650w, https:\/\/rightfoundation.kr\/en\/wp-content\/uploads\/sites\/2\/2026\/06\/skbio-550x413.jpg 550w, https:\/\/rightfoundation.kr\/en\/wp-content\/uploads\/sites\/2\/2026\/06\/skbio-460x345.jpg 460w, https:\/\/rightfoundation.kr\/en\/wp-content\/uploads\/sites\/2\/2026\/06\/skbio-450x338.jpg 450w, https:\/\/rightfoundation.kr\/en\/wp-content\/uploads\/sites\/2\/2026\/06\/skbio-350x263.jpg 350w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-7b42229c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7b42229c\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-1a79e19b\" data-id=\"1a79e19b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f1d567a elementor-align-left elementor-mobile-align-left elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-mobile elementor-widget elementor-widget-button\" data-id=\"f1d567a\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a href=\"https:\/\/www.skbioscience.com\/en\/news\/news_01_01?mode=2&#038;id=342&#038;page=1\" target=\"_blank\" rel=\"nofollow\" class=\"elementor-button-link elementor-button elementor-size-sm\" role=\"button\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-text\">Article<\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-217a68c1\" data-id=\"217a68c1\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5749a4b7 elementor-align-right elementor-mobile-align-left elementor-widget elementor-widget-button\" data-id=\"5749a4b7\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a href=\"\/en\/partner-news\/\" class=\"elementor-button-link elementor-button elementor-size-sm\" role=\"button\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-text\">Partner News List<\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-54a5a5cf elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"54a5a5cf\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-341b078a\" data-id=\"341b078a\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>The RIGHT Foundation has been supporting KRW 1,288,012,992 since 2025 for the &#8220;Inactivated Rotavirus Vaccine Development&#8221; project. Through this project, SK bioscience has entered into a license agreement with the U.S. CDC for an injectable rotavirus vaccine candidate and initiated its development toward future clinical trials and commercialization. SK bioscience, a global innovative vaccine and&#8230;<\/p>\n","protected":false},"author":1,"featured_media":11548,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[9],"tags":[],"jetpack_featured_media_url":"https:\/\/rightfoundation.kr\/en\/wp-content\/uploads\/sites\/2\/2026\/03\/sk.png","_links":{"self":[{"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/posts\/11916"}],"collection":[{"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/comments?post=11916"}],"version-history":[{"count":22,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/posts\/11916\/revisions"}],"predecessor-version":[{"id":11939,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/posts\/11916\/revisions\/11939"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/media\/11548"}],"wp:attachment":[{"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/media?parent=11916"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/categories?post=11916"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rightfoundation.kr\/en\/wp-json\/wp\/v2\/tags?post=11916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}